These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8915521)

  • 1. In vitro analysis of the mode of action of the immuno-suppressive drug 15-deoxyspergualin.
    Waaga AM; Krzymański M; Ulrichs K; Treumer J; Oko A; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):155-63. PubMed ID: 8915521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 15-deoxyspergualin on MHC class I and II antigen expression following small bowel transplantation in rats.
    Fändrich F; Waaga AM; Jacob S; Schröder J; Schweizer E; Schroeder P
    Transplant Proc; 1994 Jun; 26(3):1592-3. PubMed ID: 8030051
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of specific tolerance by 15-deoxyspergualin (DOS) treatment after rat skin and kidney transplantation in rats. Analysis of effectivity of various protocols of DOS application.
    Waaga AM; Krzymański M; Ulrichs K; Oko A; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):143-53. PubMed ID: 8915520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a rat kidney perfusion using the anti-MHC class II monoclonal antibody and reduced dose of 15-deoxyspergualine on the allogeneic graft survival.
    Oko A; Krzymański M; Deja A; Ulrichs K; Waaga AM; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):293-7. PubMed ID: 8744649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses.
    Waaga AM; Ulrichs K; Krzymanski M; Treumer J; Hansmann ML; Rommel T; Müller-Ruchholtz W
    Transplant Proc; 1990 Aug; 22(4):1613-4. PubMed ID: 2389421
    [No Abstract]   [Full Text] [Related]  

  • 6. 15-deoxyspergualin downregulates MHC class II antigen expression and cell migration in models of graft-versus-host and host-versus-graft disease.
    Waaga AM; Fändrich F; Krzymanski M; Eckstein V; Herwartz C; Muller-Ruchholtz W; Russell ME
    Transplant Proc; 1996 Oct; 28(5):2515-7. PubMed ID: 8907930
    [No Abstract]   [Full Text] [Related]  

  • 7. Deoxyspergualin inhibits mesangial cell proliferation and major histocompatibility complex class II expression.
    Nikolic-Paterson DJ; Tesch GH; Lan HY; Foti R; Atkins RC
    J Am Soc Nephrol; 1995 May; 5(11):1895-902. PubMed ID: 7620087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats.
    Matia I; Fellmer P; Splith K; Varga M; Adamec M; Kämmerer I; Feldbrügge L; Krenzien F; Hau HM; Atanasov G; Schmelzle M; Jonas S
    Ann Transplant; 2014 May; 19():225-32. PubMed ID: 24815872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of recipient pretreatment with donor spleen cells and 15-deoxyspergualin on rat skin graft survival.
    Krzymański M; Oko A; Waaga AM; Pawliczak E; Wiktorowicz K
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):459-63. PubMed ID: 9437503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive mechanism of 15-deoxyspergualin on sinusoidal lining cells in swine liver transplantation: suppression of MHC class II antigens and interleukin-1 production.
    Takasu S; Sakagami K; Morisaki F; Kawamura T; Haisa M; Oiwa T; Inagaki M; Hasuoka H; Kurozumi Y; Orita K
    J Surg Res; 1991 Aug; 51(2):165-9. PubMed ID: 1865676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
    Frisch M; Gradehandt G; Mühlradt PF
    Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of macrophage function and prolongation of graft survival by the new guanidinic-like structure, 15-deoxyspergualin.
    Dickneite G; Schorlemmer HU; Sedlacek HH; Falk W; Ulrichs K; Müller-Ruchholtz W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1301-4. PubMed ID: 3547862
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of major histocompatibility complex antigens and induction of human T-lymphocyte proliferation by astrocytes and macrophages from porcine fetal brain.
    Brevig T; Kristensen T; Zimmer J
    Exp Neurol; 1999 Oct; 159(2):474-83. PubMed ID: 10506518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility antigen class II expressing resting porcine T lymphocytes are potent antigen-presenting cells in mixed leukocyte culture.
    Saalmüller A; Maurer S
    Immunobiology; 1994 Feb; 190(1-2):23-34. PubMed ID: 8082885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.